BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25942574)

  • 1. Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis.
    van Heemst J; Jansen DT; Polydorides S; Moustakas AK; Bax M; Feitsma AL; Bontrop-Elferink DG; Baarse M; van der Woude D; Wolbink GJ; Rispens T; Koning F; de Vries RR; Papadopoulos GK; Archontis G; Huizinga TW; Toes RE
    Nat Commun; 2015 May; 6():6681. PubMed ID: 25942574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis: Clues to the HLA-RA connection from T-cell crossreactivity to vinculin and microorganisms.
    Onuora S
    Nat Rev Rheumatol; 2015 Jul; 11(7):384. PubMed ID: 26009294
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
    van der Woude D; Lie BA; Lundström E; Balsa A; Feitsma AL; Houwing-Duistermaat JJ; Verduijn W; Nordang GB; Alfredsson L; Klareskog L; Pascual-Salcedo D; Gonzalez-Gay MA; Lopez-Nevot MA; Valero F; Roep BO; Huizinga TW; Kvien TK; Martín J; Padyukov L; de Vries RR; Toes RE
    Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism.
    Kanaan SB; Sensoy O; Yan Z; Gadi VK; Richardson ML; Nelson JL
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19600-19608. PubMed ID: 31501349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules.
    Kampstra AS; van Heemst J; Moustakas AK; Papadopoulos GK; Huizinga TW; Toes RE
    Arthritis Res Ther; 2016 Nov; 18(1):254. PubMed ID: 27809896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis.
    Scally SW; Petersen J; Law SC; Dudek NL; Nel HJ; Loh KL; Wijeyewickrema LC; Eckle SB; van Heemst J; Pike RN; McCluskey J; Toes RE; La Gruta NL; Purcell AW; Reid HH; Thomas R; Rossjohn J
    J Exp Med; 2013 Nov; 210(12):2569-82. PubMed ID: 24190431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II and rheumatoid arthritis: the bumpy road of revelation.
    Kampstra ASB; Toes REM
    Immunogenetics; 2017 Aug; 69(8-9):597-603. PubMed ID: 28695293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining the HLA and RA association: to be or not to be anti-CCP positive.
    de Vries RR; Huizinga TW; Toes RE
    J Autoimmun; 2005; 25 Suppl():21-5. PubMed ID: 16257178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMA.
    de Vries RR; Huizinga TW; Toes RE
    Hum Immunol; 2006 Jun; 67(6):454-9. PubMed ID: 16728269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.
    Nordang GB; Flåm ST; Maehlen MT; Kvien TK; Viken MK; Lie BA
    Rheumatology (Oxford); 2013 Nov; 52(11):1973-82. PubMed ID: 23901134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
    Lundberg K; Bengtsson C; Kharlamova N; Reed E; Jiang X; Kallberg H; Pollak-Dorocic I; Israelsson L; Kessel C; Padyukov L; Holmdahl R; Alfredsson L; Klareskog L
    Ann Rheum Dis; 2013 May; 72(5):652-8. PubMed ID: 22661643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.
    Laki J; Lundström E; Snir O; Rönnelid J; Ganji I; Catrina AI; Bengtsson C; Saevarsdottir S; Wick MC; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2012 Jul; 64(7):2078-84. PubMed ID: 22307773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
    Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid Arthritis.
    Chemin K; Pollastro S; James E; Ge C; Albrecht I; Herrath J; Gerstner C; Tandre K; Sampaio Rizzi T; Rönnblom L; Catrina A; Holmdahl R; Klareskog L; de Vries N; Malmström V
    Arthritis Rheumatol; 2016 May; 68(5):1124-35. PubMed ID: 26713667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the frequency of HLA-DRB1 alleles in Brazilian patients with rheumatoid arthritis.
    Usnayo MJ; Andrade LE; Alarcon RT; Oliveira JC; Silva GM; Bendet I; Burlingame R; Porto LC; Pinheiro Gda R
    Rev Bras Reumatol; 2011; 51(5):474-83. PubMed ID: 21952999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.